Transcatheter aortic valve replacement in patients with reduced left ventricular ejection fraction
Abstract
Introduction. The risk of endovascular interventions in various forms of cardiac pathology is significantly lower than in surgical correction of similar conditions under cardiopulmonary bypass.
The aim of the study was to evaluate the dynamics of key indicators of central hemodynamics following transcatheter aortic valve implantation (TAVI) in patients with severe aortic stenosis and reduced left ventricular contractile function.
Materials and methods: 22 TAVI procedures were performed (13 men and 9 women) in patients with severe aortic stenosis combined with severe systolic dysfunction of the left ventricle. The functional class of heart failure according to NYHA was: Class III - 15 patients, Class IV - 7 patients. The average age was 65.6±2.18 years (ranging from 44 to 78 years).
Results. On average, there was a 30% increase in the left ventricular ejection fraction (LVEF) from 27.5 ± 2.9% to 41.2 ± 6.1% (P<0.001). There was a significant decrease in left ventricular volume. The left ventricular end-diastolic volume decreased from 176.3 ± 54.2 ml to 140.4 ± 40.1 ml (P<0.001). A significant improvement in central hemodynamics was confirmed by a substantial reduction in pulmonary artery pressure, which approached normal values - 34.3 ± 1.3 mmHg, compared to the initial value of 65±2.4 mmHg (P<0.001). The results of TAVI in patients with severe systolic dysfunction of the left ventricle demonstrate a radical improvement in cardiac performance. The degree of change in central hemodynamic parameters after the elimination of aortic stenosis reflects the level of myocardial functional reserve and may serve as a real criterion for determining of the prognosis of the disease.
Conclusion: Data from instrumental investigations performed in the postoperative period indicate a high level of technical and clinical success in performing TAVI in patients with reduced left ventricular contractile function.
About the Authors
D. A. IzotovRussian Federation
Dmitrii Izotov
1, Schukinskaya str., Moscow, 123182
Phone: (926) 184-20-65
I. G. Ryadovoy
Russian Federation
1, Schukinskaya str., Moscow, 123182
S. A. Sakhovskiy
Russian Federation
1, Schukinskaya str., Moscow, 123182
Y. V. Semenova
Russian Federation
1, Schukinskaya str., Moscow, 123182
G. V. Aniskevich
Russian Federation
1, Schukinskaya str., Moscow, 123182
E. A. Spirina
Russian Federation
1, Schukinskaya str., Moscow, 123182
V. N. Poptsov
Russian Federation
1, Schukinskaya str., Moscow, 123182
B. L. Mironkov
Russian Federation
1, Schukinskaya str., Moscow, 123182
References
1. Kamperidis V, Delgado V, van Mieghem NM, Kappetein AP, Leon MB, Bax JJ. Diagnosis and management of aortic valve stenosis in patients with heart failure. Eur J Heart Fail. 2016;18(5):469-481. doi:10.1002/ejhf.466
2. Dahl JS, Eleid MF, Michelena HI, et al. Effect of left ventricular ejection fraction on postoperative outcome in patients with severe aortic stenosis undergoing aortic valve replacement. Circ Cardiovasc Imaging. 2015;8(4):e002917. doi:10.1161/CIRCIMAGING.114.002917
3. Henkel DM, Malouf JF, Connolly HM, et al. Asymptomatic left ventricular systolic dysfunction in patients with severe aortic stenosis: characteristics and outcomes. J Am Coll Cardiol. 2012;60(22):2325-2329. doi:10.1016/j.jacc.2012.08.988
4. Spilias N, Martyn T, Denby KJ, Harb SC, Popovic ZB, Kapadia SR. Left Ventricular Systolic Dysfunction in Aortic Stenosis: Pathophysiology, Diagnosis, Management, and Future Directions. Struct Heart. 2022;6(5):100089. doi:10.1016/j.shj.2022.100089
5. Steiner J, Rodés-Cabau J, Holmes DR, LeWinter MM, Dauerman HL. Mechanical Intervention for Aortic Valve Stenosis in Patients With Heart Failure and Reduced Ejection Fraction. J Am Coll Cardiol. 2017;70(24):3026-3041. doi:10.1016/j.jacc.2017.10.040
6. Spitzer E, Ren B, Kroon H, et al. Moderate Aortic Stenosis and Reduced Left Ventricular Ejection Fraction: Current Evidence and Challenges Ahead. Front Cardiovasc Med. 2018;5:111. doi:10.3389/fcvm.2018.00111
7. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/ EACTS Guidelines for the management of valvular heart disease. European heart journal. 2017;38(36):2739- 2786. doi:10.1093/EURHEARTJ/EHX391
8. Bavishi C, Kolte D, Gordon PC, Abbott JD. Transcatheter aortic valve replacement in patients with severe aortic stenosis and heart failure. Heart Fail Rev. 2018;23(6):821-829. doi:10.1007/s10741-018-9726-8
9. Jalava MP, Savontaus M, Ahvenvaara T, et al. Transcatheter and surgical aortic valve replacement in patients with left ventricular dysfunction. J Cardiothorac Surg. 2022;17:322. doi:10.1186/s13019-022-02061-9
10. Passeri JJ, Elmariah S, Xu K, et al. Transcatheter aortic valve replacement and standard therapy in inoperable patients with aortic stenosis and low EF. Heart. 2015;101(6):463-471. doi:10.1136/heartjnl-2014-306737
11. Ричард Э. Клабунде/ перевод с англ. Под ред. Сухова В.К. Принципы сердечно-сосудистой системы / «Cardiovascular Physiology Concepts» – СПб: «Экстен Медикал», 2021. - 416 с. ISBN 978-5-6047163-1-1
Review
For citations:
Izotov D.A., Ryadovoy I.G., Sakhovskiy S.A., Semenova Y.V., Aniskevich G.V., Spirina E.A., Poptsov V.N., Mironkov B.L. Transcatheter aortic valve replacement in patients with reduced left ventricular ejection fraction. Minimally Invasive Cardiovascular Surgery. 2024;3(4):11-15. (In Russ.)